 |
市場調查報告書
商品編碼
1568886
醫療科技部門的研發投資分析R&D Investment Analysis of the Medtech Sector |
||||||
人工智慧與醫療設備小型化的融合將推動變革性成長
在 COVID-19 大流行之前，醫療科技（medtech）在研發方面進行了大量投資。然而，儘管疫情後投資趨勢有所下降，但正逐漸恢復動能。頂級醫療科技公司將其總收入的約 7%至 8%投資於新產品的研發和現有產品的增強。醫療科技研發投資的主要來源是企業預算、創業投資和私募股權公司、政府津貼、公共資金以及夥伴關係和合作。
Frost & Sullivan 對醫療科技研發投資的研究包括成長動力和阻礙因素、併購交易分析（包括2022年頂級交易）、區域分析、影響醫療科技研發投資的外部因素分析、未來 10年的預測和關鍵。了公司的成長機會。
本研究重點關注循環系統和神經病學這兩個主要治療領域，並重點介紹與主要研發投資和主要併購活動（包括近期的）相關的關鍵技術趨勢。
循環系統的投資主要集中在基於人工智慧的先進診斷工具、植入小型化、遠端患者監護和微創手術技術。
神經學領域的投資主要集中在神經調節設備、植入和穿戴式監測設備的創新。
分析中回答的關鍵問題
醫療科技研發投入的主要成長要素與阻礙因素有哪些？循環系統和神經科醫療科技研發投入的主要技術趨勢是什麼？循環系統和神經病學的主要研發投資活動有哪些？循環系統和神經病學領域的主要併購活動有哪些？從2022年5大併購交易分析可以看出什麼？從醫療科技研發投入的區域分析可以看出什麼？哪些外在因素影響醫療科技研發投入？對未來10年醫療科技研發投入有何預測？市場參與企業的主要成長機會是什麼？
目錄
戰略問題
- 為什麼成長越來越困難？
- The Strategic Imperative 8（TM）
- 三大策略重點對醫療科技產業研發投入的影響
- 成長機會是Growth Pipeline Engine（TM）
- 調查方法
成長機會分析
- 分析範圍
- 醫療科技研發投入及主要目標
- 醫療科技研發投入來源
- 2023年四大醫療設備生產企業研發費用狀況
- 依治療領域細分
成長要素
- 生長促進因子
- 成長抑制因素
細分分析：循環系統領域
- 醫療科技：研發投入主要技術趨勢：循環系統領域
- 醫療科技：循環系統領域研發投入（2024年）
- 醫療科技：循環系統領域研發投入（2023年）
- 醫療科技：循環系統領域主要併購活動：循環系統領域（2024年）
細分分析：神經領域
- 醫療科技：研發投資主要技術趨勢：神經病學
- 醫療科技：神經病學研發投資（2024）
- 醫療科技：神經病學研發投資（2023）
- 醫療科技：神經病學領域的主要併購活動
市場分析
- 醫療科技領域併購交易金額
- 2022年 5 大併購交易
- 區域分析
- 外在因素對醫療科技研發投入的影響
- 未來10年的預測
醫療科技研發領域充滿成長機會
- 成長機會1：新興國家的研發投入
- 成長機會2：微創產品與AI融合
- 成長機會3：持續病患監測解決方案
附錄
- 技術成熟度等級（TRL）：解釋
下一步
- 成長機會的好處和影響
- 下一步
- 免責聲明
Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth
Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medtech R&D investments are corporate budgets, venture capital and private equity firms, government grants, public funding, and partnerships and collaborations.
This Frost & Sullivan research on medtech R&D investment covers growth drivers and restraints; analysis of M&A deals, including the top deals in 2022; regional analysis; analysis of external factors impacting medtech R&D investment; predictions for the next decade; and key growth opportunities for companies.
The study focuses on cardiology and neurology as two top therapy areas covering key technological trends involved with significant R&D investments, including recent ones, and major M&A activities.
Investments in cardiology are focused on advanced AI-based diagnostic tools, implant miniaturization, remote patient monitoring, and minimally invasive techniques for surgery.
Investments in neurology are focused on innovation in neuromodulation devices, implants, and wearable monitoring devices.
Key Questions Answered in the Analysis:
What are the key growth drivers and restraints for medtech R&D investment? What are the key technological trends for medtech R&D investment for cardiology and neurology? What are the key R&D investment activities in cardiology and neurology? What are the key M&A activities in cardiology and neurology? What does the analysis of the top 5 M&A deals in 2022 reveal? What does the regional analysis for medtech R&D investment reveal? What external factors impact medtech R&D investments? What are the predictions for medtech R&D investment during the next decade? What are the key growth opportunities for market participants?
Table of Contents
Strategic Imperatives
- Why Is It Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on R&D Investment in the Medtech Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
- Research Methodology
Growth Opportunity Analysis
- Scope of Analysis
- Medtech R&D Investments and Key Goals
- Sources of Medtech R&D Investment
- R&D Spending by Top 4 Medical Devices Companies in 2023
- Segmentation by Therapy Areas*
Growth Generator
- Growth Drivers
- Growth Restraints
Segment Analysis: Cardiology
- Major Technological Trends in R&D Investments for Medtech: Cardiology
- Key R&D Investments in Medtech: Cardiology (2024)
- Key R&D Investments in Medtech: Cardiology (2023)
- Key M&A Activities in Medtech: Cardiology (2024)
Segment Analysis: Neurology
- Major Technological Trends in R&D Investments for Medtech: Neurology
- Key R&D Investments in Medtech: Neurology (2024)
- Key R&D Investments in Medtech: Neurology (2023)
- Key M&A Activities in Medtech: Neurology
Market Analysis
- Value of M&A Deals in Medical Technology
- Top 5 M&A Deals of 2022
- Regional Analysis
- Impact of External Factors on Medtech R&D Investments
- Predictions for the Next Decade
Growth Opportunity Universe in Medtech R&D
- Growth Opportunity 1: R&D Investment in Developing Countries
- Growth Opportunity 2: Minimally Invasive Products and AI Integration
- Growth Opportunity 3: Continuous Patient Monitoring Solutions
Appendix
- Technology Readiness Levels (TRL): Explanation
Next Steps
- Benefits and Impacts of Growth Opportunities
- Next Steps
- Legal Disclaimer
